Amgen Inc (AMGN)
268.94
+6.20
(+2.36%)
USD |
NASDAQ |
Apr 19, 16:00
270.75
+1.80
(+0.67%)
After-Hours: 20:00
Amgen Total Liabilities (Quarterly): 90.92B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 90.92B |
| September 30, 2023 | 82.88B |
| June 30, 2023 | 83.49B |
| March 31, 2023 | 83.37B |
| December 31, 2022 | 61.46B |
| September 30, 2022 | 60.05B |
| June 30, 2022 | 56.88B |
| March 31, 2022 | 58.28B |
| December 31, 2021 | 54.46B |
| September 30, 2021 | 56.78B |
| June 30, 2021 | 51.53B |
| March 31, 2021 | 53.20B |
| December 31, 2020 | 53.54B |
| September 30, 2020 | 53.68B |
| June 30, 2020 | 54.35B |
| March 31, 2020 | 52.18B |
| December 31, 2019 | 50.03B |
| September 30, 2019 | 48.61B |
| June 30, 2019 | 48.58B |
| March 31, 2019 | 53.16B |
| December 31, 2018 | 53.92B |
| September 30, 2018 | 52.98B |
| June 30, 2018 | 52.78B |
| March 31, 2018 | 55.54B |
| December 31, 2017 | 54.71B |
| Date | Value |
|---|---|
| September 30, 2017 | 48.10B |
| June 30, 2017 | 47.86B |
| March 31, 2017 | 47.22B |
| December 31, 2016 | 47.75B |
| September 30, 2016 | 47.38B |
| June 30, 2016 | 45.34B |
| March 31, 2016 | 46.43B |
| December 31, 2015 | 43.37B |
| September 30, 2015 | 43.90B |
| June 30, 2015 | 43.72B |
| March 31, 2015 | 42.45B |
| December 31, 2014 | 43.23B |
| September 30, 2014 | 45.45B |
| June 30, 2014 | 45.15B |
| March 31, 2014 | 44.26B |
| December 31, 2013 | 44.03B |
| September 30, 2013 | 35.34B |
| June 30, 2013 | 32.02B |
| March 31, 2013 | 32.15B |
| December 31, 2012 | 35.24B |
| September 30, 2012 | 35.55B |
| June 30, 2012 | 32.99B |
| March 31, 2012 | 30.38B |
| December 31, 2011 | 29.84B |
| September 30, 2011 | 22.21B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
48.58B
Minimum
Jun 2019
90.92B
Maximum
Dec 2023
60.75B
Average
54.46B
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 39.38B |
| Johnson & Johnson | 98.78B |
| Eli Lilly and Co | 53.14B |
| Merck & Co Inc | 69.04B |
| Vertex Pharmaceuticals Inc | 5.150B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 97.15B |
| Shareholders Equity (Quarterly) | 6.232B |
| Debt to Equity Ratio | 10.37 |
| Current Ratio | 1.649 |
| Net Debt Paydown Yield | -3.36% |